BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 37728696)

  • 1. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease.
    Mezalek ZT; Feodor T; Chernukha L; Chen Z; Rueda A; Sánchez IE; Ochoa AJG; Chirol J; Blanc-Guillemaud V; Lohier-Durel C; Ulloa JH
    Adv Ther; 2023 Nov; 40(11):5016-5036. PubMed ID: 37728696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
    Kakkos SK; Nicolaides AN
    Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
    Jantet G
    Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micronized purified flavonoid fraction-based conservative treatment of chronic venous disease in a real-world setting.
    Bogachev V; Boldin B; Turkin P; Samenkov A; Dzhenina O
    Future Cardiol; 2022 Sep; 18(10):777-785. PubMed ID: 36004765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Insights for the Appropriate Management of Chronic Venous Disease: A Narrative Review of Implications for the Use of Venoactive Drugs.
    Gianesini S; De Luca L; Feodor T; Taha W; Bozkurt K; Lurie F
    Adv Ther; 2023 Dec; 40(12):5137-5154. PubMed ID: 37768506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of Micronized Purified Flavonoid Fraction During Sclerotherapy of Reticular Veins and Telangiectasias: Results of the National, Multicenter, Observational Program VEIN ACT PROLONGED-C1.
    Bogachev VY; Boldin BV; Turkin PY
    Adv Ther; 2018 Jul; 35(7):1001-1008. PubMed ID: 29949043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids.
    Jantet G
    Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of micronized purified flavonoid fraction in treatment of chronic venous oedema].
    Bogachev VI; Boldin BV; Turkin PI; Samenkov AI
    Angiol Sosud Khir; 2020; 26(2):86-94. PubMed ID: 32597888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of MPFF 1000 mg oral suspension on CVD C0s-C1-related symptoms and quality of life.
    Maggioli A; Carpentier P
    Int Angiol; 2019 Apr; 38(2):83-89. PubMed ID: 31056892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and safety of a new 1000-mg suspension versus twice-daily 500-mg tablets of MPFF in patients with symptomatic chronic venous disorders: a randomized controlled trial.
    Carpentier P; van Bellen B; Karetova D; Hanafiah H; Enriquez-Vega E; Kirienko A; Dzupina A; Sabovic M; Reina Gutierrez L; Subwongcharoen S; Tüzün H; Maggioli A
    Int Angiol; 2017 Oct; 36(5):402-409. PubMed ID: 28206732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial.
    Rabe E; Agus GB; Roztocil K
    Int Angiol; 2015 Oct; 34(5):428-36. PubMed ID: 25972136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
    Ulloa JH
    Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic literature review and expert meeting report on health-related quality of life in chronic venous disease.
    Ulloa JH; Lurie F; Santiago FR; Gianesini S; Reina L; Wang J; Jindal R; Taha W; Bokuchava M; Mansilha A
    Int Angiol; 2023 Dec; 42(6):465-476. PubMed ID: 38015554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of once-daily micronized purified flavonoid fraction 1000 mg tablet in patients with symptomatic chronic venous disease.
    Kirienko A; Radak D; Maggioli A
    Curr Med Res Opin; 2019 Mar; 35(3):553-557. PubMed ID: 29992831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative efficacy of various methods of treatment of chronic venous oedema in real clinical practice].
    Bogachev VI; Boldin BV; Turkin PI; Samenkov AI;
    Angiol Sosud Khir; 2021; 27(3):77-83. PubMed ID: 34528591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daflon 500 mg: symptoms and edema clinical update.
    Ramelet AA
    Angiology; 2005; 56 Suppl 1():S25-32. PubMed ID: 16193223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Benefits of Micronized Purified Flavonoid Fraction (MPFF) Throughout the Progression of Chronic Venous Disease.
    Nicolaides AN
    Adv Ther; 2020 Feb; 37(Suppl 1):1-5. PubMed ID: 31970659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Efficacy of Conservative Treatment with Micronized Purified Flavonoid Fraction in Female Patients with Pelvic Congestion Syndrome.
    Akhmetzianov RV; Bredikhin RA
    Pain Ther; 2021 Dec; 10(2):1567-1578. PubMed ID: 34537951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.
    Cazaubon M; Benigni JP; Steinbruch M; Jabbour V; Gouhier-Kodas C
    Vasc Health Risk Manag; 2021; 17():591-600. PubMed ID: 34556990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease: From Microvalves to Clinical Effectiveness.
    Bouskela E; Lugli M; Nicolaides A
    Adv Ther; 2022 Oct; 39(10):4413-4422. PubMed ID: 35951224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.